An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This protocol is designed to evaluate the metabolic effects of adding exenatide,
rosiglitazone, or both to an existing regimen of metformin in subjects with inadequate
glycemic control.